U.s. fda licenses certara's immunogenicity simulator

Affirms the advancements of innovative biosimulation technology and its growing impact in r&d affirms the advancements of innovative biosimulation technology and its growing impact in r&d

CERT Ratings Summary

CERT Quant Ranking